glp 1 approved for heart disease GLP-1 medications are not just weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major The benefits of GLP1 receptors
Description
Novo's Wegovy pill already has over 600,000 prescriptions since it was approved in December, and Foundayo doesn't require fasting which is a major differentiator

bottle closed tightly

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine

Warning: Do not exceed the recommended daily dose

Discover 5 research-backed strategies to naturally boost GLP-1 levels